ATE364390T1 - Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen - Google Patents

Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen

Info

Publication number
ATE364390T1
ATE364390T1 AT99902261T AT99902261T ATE364390T1 AT E364390 T1 ATE364390 T1 AT E364390T1 AT 99902261 T AT99902261 T AT 99902261T AT 99902261 T AT99902261 T AT 99902261T AT E364390 T1 ATE364390 T1 AT E364390T1
Authority
AT
Austria
Prior art keywords
vitamins
reducing
allium
homocystein
serum
Prior art date
Application number
AT99902261T
Other languages
English (en)
Inventor
Harunobu Amagase
Original Assignee
Wakunaga Of America Co Ltd
Harunobu Amagase
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Of America Co Ltd, Harunobu Amagase filed Critical Wakunaga Of America Co Ltd
Application granted granted Critical
Publication of ATE364390T1 publication Critical patent/ATE364390T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT99902261T 1998-08-13 1999-01-13 Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen ATE364390T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/133,267 US6129918A (en) 1998-08-13 1998-08-13 Method and pharmaceutical composition for reducing serum homocysteine concentration

Publications (1)

Publication Number Publication Date
ATE364390T1 true ATE364390T1 (de) 2007-07-15

Family

ID=22457780

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902261T ATE364390T1 (de) 1998-08-13 1999-01-13 Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen

Country Status (10)

Country Link
US (1) US6129918A (de)
EP (1) EP1105145B1 (de)
AT (1) ATE364390T1 (de)
AU (1) AU775544B2 (de)
CA (1) CA2340227C (de)
DE (1) DE69936307T2 (de)
ES (1) ES2289806T3 (de)
IL (2) IL141303A0 (de)
NZ (1) NZ509770A (de)
WO (1) WO2000009141A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9906740D0 (en) * 1999-03-23 1999-05-19 Kilgowan Limited Oral combinations of hydroxocobalamin and folic acid
FR2821947B1 (fr) * 2001-03-12 2003-05-16 Canon Kk Procede et dispositif de validation de parametres definissant une image
US20030077264A1 (en) * 2001-09-20 2003-04-24 Goodrich Laura L. Antimicrobial blood treatment using allicin and related compounds
DE10206159A1 (de) * 2002-02-14 2003-08-28 Kosmas Kg Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
DE102005001479A1 (de) * 2005-01-12 2006-07-20 Synavit Gmbh Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
WO2006084033A1 (en) * 2005-02-03 2006-08-10 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
DE102005009379A1 (de) 2005-03-01 2006-09-07 Synavit Gmbh Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
US7201929B1 (en) * 2005-12-30 2007-04-10 Alan James Group, Llc. Aspirin formulation for cardiovascular health
US8586537B2 (en) * 2006-05-25 2013-11-19 Rick Tope Method for treating minor aphthous ulcers
US20080045448A1 (en) * 2006-08-18 2008-02-21 Alan Robert Vinitsky Reversing autonomic nervous system dysfunction by potentiating methylation
BRPI0818007A2 (pt) * 2007-10-16 2015-11-03 Exichol Sa composição para regular o metabolismo lipídico
US20150290323A1 (en) * 2014-04-11 2015-10-15 Sam Houston State University Dialkyl trisulfides and formulations of dialkyl trisulfides for use as a cyanide antidote
CN103976331A (zh) * 2014-05-28 2014-08-13 彭常安 一种荞头茎叶调味粉的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6067409A (ja) * 1983-09-22 1985-04-17 Suntory Ltd 頭髪用化粧料
US4737364A (en) * 1986-02-06 1988-04-12 Kalogris Theodore P Nutritional dry food concentrate
US5231114A (en) * 1990-06-22 1993-07-27 Wakunaga Seiyaku Kabushiki Kaisha Polysulfides compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient
WO1995015750A1 (en) * 1993-12-10 1995-06-15 Hashim Sami A Reducing likelihood of vascular disorders in susceptible patients
JP2608252B2 (ja) * 1994-09-16 1997-05-07 名古屋製酪株式会社 ニンニクの加工処理方法およびアホエン含有油脂の製造方法
CN1123113A (zh) * 1994-11-18 1996-05-29 郭湘泗 用于特效减肥的超浓缩营养素

Also Published As

Publication number Publication date
EP1105145A4 (de) 2004-04-07
AU2228399A (en) 2000-03-06
AU775544B2 (en) 2004-08-05
DE69936307T2 (de) 2008-02-14
US6129918A (en) 2000-10-10
NZ509770A (en) 2003-08-29
IL141303A0 (en) 2002-03-10
EP1105145A1 (de) 2001-06-13
ES2289806T3 (es) 2008-02-01
CA2340227A1 (en) 2000-02-24
DE69936307D1 (de) 2007-07-26
CA2340227C (en) 2011-01-11
EP1105145B1 (de) 2007-06-13
IL141303A (en) 2006-08-20
WO2000009141A1 (en) 2000-02-24

Similar Documents

Publication Publication Date Title
DE69936307D1 (de) Verringerung der homocysteinkonzentration im serum mittels allium und vitaminen
EA199800805A1 (ru) Пероральная фармацевтическая форма лекарственного препарата в виде множественной дозированной формы с модифицированным высвобождением
CO5251419A1 (es) Composiciones nanoparticuladas de eplerenona
EA200100872A1 (ru) Композиция валдекоксиба
YU48600A (sh) Celekoksibne smese
PT1014961E (pt) Tratamento da cefaleia de enxaqueca utilizando metoclopramida e um nsaid
MXPA04004376A (es) Complementos nutricionales, y metodos para la prevencion, reduccion y tratamiento de lesion por radiacion.
DE69727158D1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
CO5160320A1 (es) Metodos y composiciones para la prevencion de tolerancia a medicamentos das.
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
ATE468126T1 (de) Ingwer-extraktzubereitung
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
ATE272628T1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
DE60128912D1 (en) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
EA200400357A1 (ru) Дезинтегрирующиеся в ротовой полости композиции валдекоксиба
IL160232A0 (en) Oral compositions for the treatment of scalp disorders
NO975858L (no) Anvendelse av et ekstrakt av Cimicifuga racemosa
UA66856C2 (uk) Тієнопіримідини, спосіб їх одержання, фармацевтична композиція та спосіб її одержання
WO2004010946A3 (en) Therapeutic treatment for the metabolic syndrome and type 2 diabetes
ATE290388T1 (de) Kombination von selen-haltigen verbindungen mit gemcitabin oder mitomycin c
NZ326345A (en) Composition containing diosgenin
SE8403659D0 (sv) Synergistic pharmaceutical composition
DE60236443D1 (de) Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie
DK0991409T3 (da) Farmaceutiske tiagabinindeholdende præparater med reguleret frigivelse
UY24181A1 (es) Método para tratar un infarto de miocardio agudo con hirudina y ácido acetilsalicílico en pacientes no sometidos a tratamiento trombolítico

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties